These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 33802308)

  • 41. Revisiting the Cardioprotective Effects of Acetylcholine Receptor Activation against Myocardial Ischemia/Reperfusion Injury.
    Intachai K; C Chattipakorn S; Chattipakorn N; Shinlapawittayatorn K
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchanger.
    Bouwman RA; Salic K; Padding FG; Eringa EC; van Beek-Harmsen BJ; Matsuda T; Baba A; Musters RJ; Paulus WJ; de Lange JJ; Boer C
    Circulation; 2006 Jul; 114(1 Suppl):I226-32. PubMed ID: 16820577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The novel H
    Testai L; Marino A; Piano I; Brancaleone V; Tomita K; Di Cesare Mannelli L; Martelli A; Citi V; Breschi MC; Levi R; Gargini C; Bucci M; Cirino G; Ghelardini C; Calderone V
    Pharmacol Res; 2016 Nov; 113(Pt A):290-299. PubMed ID: 27616550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of 5 different remifentanil strategies against myocardial ischemia-reperfusion injury.
    Chun KJ; Park YH; Kim JS; Jang Y; Kim JH; Kim J; Lee MY
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):926-30. PubMed ID: 21514843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical translation of myocardial conditioning.
    Bøtker HE; Lassen TR; Jespersen NR
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1225-H1252. PubMed ID: 29498531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse.
    Nishino Y; Webb IG; Davidson SM; Ahmed AI; Clark JE; Jacquet S; Shah AM; Miura T; Yellon DM; Avkiran M; Marber MS
    Circ Res; 2008 Aug; 103(3):307-14. PubMed ID: 18583716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardioprotection by volatile anesthetics.
    Bienengraeber MW; Weihrauch D; Kersten JR; Pagel PS; Warltier DC
    Vascul Pharmacol; 2005; 42(5-6):243-52. PubMed ID: 15922257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenylephrine induces early and late cardioprotection through mitochondrial permeability transition pore in the isolated rat heart.
    Naderi R; Imani A; Faghihi M; Moghimian M
    J Surg Res; 2010 Nov; 164(1):e37-42. PubMed ID: 20850771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pre-conditioning and postconditioning to limit ischemia-reperfusion-induced myocardial injury: what could be the next footstep?
    Balakumar P; Rohilla A; Singh M
    Pharmacol Res; 2008 Jun; 57(6):403-12. PubMed ID: 18586514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Conditioning the heart in cardiac surgery].
    Deja MA; Malinowski M
    Kardiol Pol; 2011; 69 Suppl 3():80-4. PubMed ID: 22125208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Roles of cyclooxygenase 2 in sevoflurane- and olprinone-induced early phase of preconditioning and postconditioning against myocardial infarction in rat hearts.
    Tosaka S; Tosaka R; Matsumoto S; Maekawa T; Cho S; Sumikawa K
    J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):72-8. PubMed ID: 20938040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thyroid hormone postconditioning protects hearts from ischemia/reperfusion through reinforcing mitophagy.
    Bi W; Jia J; Pang R; Nie C; Han J; Ding Z; Liu B; Sheng R; Xu J; Zhang J
    Biomed Pharmacother; 2019 Oct; 118():109220. PubMed ID: 31357081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
    Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Icariin Exerts Protective Effect Against Myocardial Ischemia/Reperfusion Injury in Rats.
    Meng X; Pei H; Lan C
    Cell Biochem Biophys; 2015 Sep; 73(1):229-35. PubMed ID: 25724443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Binding of elastin peptides to S-Gal protects the heart against ischemia/reperfusion injury by triggering the RISK pathway.
    Robinet A; Millart H; Oszust F; Hornebeck W; Bellon G
    FASEB J; 2007 Jul; 21(9):1968-78. PubMed ID: 17341689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological postconditioning with Neuregulin-1 mimics the cardioprotective effects of ischaemic postconditioning via ErbB4-dependent activation of reperfusion injury salvage kinase pathway.
    Wang F; Wang H; Liu X; Yu H; Zuo B; Song Z; Wang N; Huang W; Wang G
    Mol Med; 2018 Jul; 24(1):39. PubMed ID: 30134819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
    Chang JH; Jin MM; Liu JT
    Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
    Sivarajah A; McDonald MC; Thiemermann C
    Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of phosphoinositide 3-kinase IA (PI3K-IA) activation in cardioprotection induced by ouabain preconditioning.
    Duan Q; Madan ND; Wu J; Kalisz J; Doshi KY; Haldar SM; Liu L; Pierre SV
    J Mol Cell Cardiol; 2015 Mar; 80():114-25. PubMed ID: 25575882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel therapeutic strategies for ischemic heart disease.
    Perricone AJ; Vander Heide RS
    Pharmacol Res; 2014 Nov; 89():36-45. PubMed ID: 25193582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.